Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
384,317,619
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
3,288,318
-
Shares change
-
-22,640
-
Total reported value, excl. options
-
$12,166,000
-
Value change
-
-$117,042
-
Number of buys
-
4
-
Number of sells
-
-5
-
Price
-
$3.7
Significant Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q2 2022
17 filings reported holding CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares as of Q2 2022.
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,288,318 shares
of 384,317,619 outstanding shares and own 0.86% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2,578,174 shares), Cormorant Asset Management, LP (288,168 shares), Ikarian Capital, LLC (268,104 shares), BOOTHBAY FUND MANAGEMENT, LLC (41,300 shares), STATE STREET CORP (36,185 shares), MEITAV DASH INVESTMENTS LTD (35,024 shares), ENVESTNET ASSET MANAGEMENT INC (12,193 shares), GEODE CAPITAL MANAGEMENT, LLC (11,737 shares), ADVISOR GROUP HOLDINGS, INC. (7,728 shares), and MORGAN STANLEY (5,595 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.